Pancreas Cancer
Conditions
Brief summary
This protocol will involve collection of blood samples from patients with a diagnosis of pancreatic adenocarcinoma for evaluation of circulating biomarkers.
Interventions
4 tbsp of blood in a 1-week period, occurring no more frequently than 4 times in an 8-week period
Sponsors
Study design
Eligibility
Inclusion criteria
* The subject must have a known or presumed diagnosis of pancreatic adenocarcinoma * The subject must be a patient of the University of Pennsylvania * The subject must be able to provide informed consent * The subject must be 18 years of age or older
Exclusion criteria
. Subjects who have any clinically significant psychiatric, social, or medical condition that, in the opinion of the investigator, could increase the patient's risk, interfere with protocol adherence, or affect the patient's ability to give informed consent are ineligible to participate in the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To create a comprehensive system to collect, catalogue and store blood specimens from subjects with pancreatic cancer for future research use. | Through study completion, an average of 1 year |
Secondary
| Measure | Time frame |
|---|---|
| To create a computerized clinical data set from subjects with pancreatic cancer that contains information related to the subject's general health, disease status, treatments, and response. | Through study completion, an average of 1 year |
| To integrate the data and specimens to permit the most informative clinical-biologic research platform. | Through study completion, an average of 1 year |
Countries
United States
Contacts
Abramson Cancer Center, University of Pennsylvania